“Uninformed” Consent: Patient Recollection From Surgical Consent in Hand Surgery—A Quality Improvement Initiative
Research Article
Monica Yu, Herbert P. von Schroeder
HAND, 5 September 2019
Abstract
Background
Informed surgical consent is necessary and routine; however, it can have significant inadequacies. Our purpose was to investigate patient recollection of the surgical consent process and evaluate adequacy from the patient’s perspective.
Methods
A quality improvement framework was used. Two patient surveys capturing information recall and satisfaction of the consent process were administered in 5 consecutive hand clinics. All patients who previously underwent elective hand surgery were included.
Results
There was exceptionally low recall of the risks and benefits of surgery in 103 consecutive patients who underwent hand surgery. Patients under age 35 had slightly better recall of surgical risks. Unexpected postoperative events affected patient perceptions of the consent process.
Conclusions
Patients who have undergone elective hand surgery have poor recollection of the information discussed during the surgical consent process, and therefore the process is lacking. Surgeons may falsely assume that the consent process is sound because it is erroneously perceived as being sufficient by most patients.
Is There a Difference Between the Readabilities of Informed Consent Forms Used for Elective and Emergency Procedures in Turkey?
Is There a Difference Between the Readabilities of Informed Consent Forms Used for Elective and Emergency Procedures in Turkey?
Research Article
Mehmet Giray Sönmez, Leyla Öztürk Sönmez, Betül Kozanhan, Zerrin Defne Dündar
Therapeutic Innovation & Regulatory Science; 5 September 2019
Abstract
Background
Informed consent is an important aspect of ethical medical practice. In legal terms, making an intervention without informed consent may mean negligence or malpractice and may lead to legal action, maltreatment, and even attack against the doctor. This study aims to evaluate the readability of informed consent forms (ICFs) used for elective (urology and general surgery) and emergency procedures (emergency medicine and intensive care) by comparing through readability formulas.
Methods
Elective and emergency ICFs were accessed through the web sites of national health care associations. A total of 387 consent forms were evaluated and the same forms were included only once. A total of 35 consent forms were evaluated for emergency procedures, while a total of 55 consent forms were evaluated for elective procedures. Ateşman and Bezirci-Yılmaz formulas defined for determining the readability level of Turkish texts and Gunning fog and Flesch Kincaid formulas measuring the general readability level were used for calculating the readability level of consent forms.
Results
Even though elective ICFs are more readable compared to those of emergency procedures according to Bezirci-Yılmaz formulas, this was statistically insignificant (P = .54). The readability of elective consent forms was found to be at a significantly more difficult level to read compared to Ateşman, Gunning fog, and Flesch Kincaid formulas (P = .002, P < .001, P < .001, respectively).
Conclusion
Even though the procedure is emergency or elective, a difficult readability level may cause problems for the doctor in legal phases. Readable and understandable consent forms should be available to be able to explain morbidity and mortality and improve prognosis. Education level of our country should also be considered while preparing these consent forms.
Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations
Utilization of a Parental Approach to Informed Consent in Intravenous Tissue Plasminogen Activator Administration Decision-Making: Patient Preference and Ethical Considerations
Research Article
Ann M. Murray, Ashley B. Petrone, Amelia K. Adcock
Neurology Research International, 5 September 2019
Abstract
Objective
While administration of intravenous tissue plasminogen activator (IV-tPA) is the standard of care in acute ischemic stroke and has been shown to have statistically significant benefit, there can also be potentially life-threatening complications; however, there is no standard informed consent approach. (e purpose of this study was to present a parental, technical, and general model of informed consent for IV-TPA and to determine which approach was preferred.
Methods
Survey respondents were asked to hypothetically decide whether or not to provide consent for their family member to receive IV-tPA. Respondents were presented with 3 informed consent models: one emphasizing parental qualities, one emphasizing statistical data, and one representing a general consent statement. After being presented each model, the respondents had to select their preferred consent model, as well as rate their level of agreeability toward their family member receiving the medication following each approach.
Results
(e results of 184 surveys showed respondents were equally as likely to give consent for their family member to receive IVTPA following all three approaches; however, respondents were significantly more likely to prefer the parental approach compared to a technical or general approach.
Conclusion
Our results indicate that while paternalism is generally discouraged in the medical community, some degree of parental language may be preferred by patients in tough decision-making situations toward consent to receive medical interventions.
Signature Informed Consent for Long-Term Opioid Therapy in Patients with Cancer: Perspectives of Patients and Providers
Signature Informed Consent for Long-Term Opioid Therapy in Patients with Cancer: Perspectives of Patients and Providers
Original Article
Karleen Giannitrapani, Soraya Fereydooni, Azin Azarfar, Maria J. Silveira, Peter A. Glassman, Amanda Midboe, Amy Bohnert, Maria Zenoni, Robert D. Kerns, Robert A. Pearlman, Steven M. Asch, William Becker, Karl A. Lorenz
Journal of Pain and Symptom Management, 30 August 2019
Abstract
Context
Signature informed consent (SIC) is a part of a Veterans Health Administration (VHA) ethics initiative for patient education and shared decision-making with long-term opioid therapy (LTOT). Historically, patients with cancer-related pain receiving LTOT are exempt from this process.
Objectives
Our objective is to understand patients’ and providers’ perspectives on using signature informed consent for LTOT in patients with cancer-related pain.
Methods
Semi-structured interviews with 20 opioid prescribers and 20 patients who were prescribed opioids at two large academically-affiliated VHA Medical Centers. We employed a combination of deductive and inductive approaches in content analysis to produce emergent themes.
Results
Potential advantages of SIC are that it can clarify and help patients comprehend LTOT risks and benefits, provide clear upfront boundaries and expectations, and involve the patient in shared decision-making. Potential disadvantages of SIC include time delay to treatment, discouragement from recommended opioid use, and impaired trust in the patient-provider relationship. Providers and patients have misconceptions about the definition of SIC. Providers and patients question if SIC for LTOT is really informed consent. Providers and patients advocate for strategies to improve comprehension of SIC content. Providers had divergent perspectives on exemptions from SIC. Oncologists want SIC for LTOT to be tailored for patients with cancer.
Conclusion
Provider and patient interviews highlight various aspects about the advantages and disadvantages of requiring SIC for LTOT in cancer-related pain. Tailoring SIC for LTOT to be specific to cancer related concerns and to have an appropriate literacy level are important considerations.
Informed Consent: A Monthly Review
___________________________
September 2019
This digest aggregates and distills key content around informed consent from a broad spectrum of peer-reviewed journals and grey literature, and from various practice domains and organization types including international agencies, INGOs, governments, academic and research institutions, consortiums and collaborations, foundations, and commercial organizations. We acknowledge that this scope yields an indicative and not an exhaustive digest product.
Informed Consent: A Monthly Review is a service of the GE2P2 Global Foundation’s Center for Informed Consent Integrity, which is solely responsible for its content. Comments and suggestions should be directed to:
Editor
Paige Fitzsimmons, MA
Associate Fellow
GE2P2 Global Foundation
paige.fitzsimmons@ge2p2global.org
Publisher
David R. Curry
President & CEO
GE2P2 Global Foundation
david.r.curry@ge2p2global.org
PDF Version: GE2P2 Global_Informed Consent – A Monthly Review_September 2019
Issues of Informed Consent from Persons with Dementia When Employing Assistive Technologies [BOOK CHAPTER]
Issues of Informed Consent from Persons with Dementia When Employing Assistive Technologies [BOOK CHAPTER]
Peter Novitzky, Cynthia Chen, Alan F. Smeaton, Renaat Verbruggen, Bert Gordijn
Intelligent Assistive Technologies for Dementia, 14 October 2019; Chapter 10
Excerpt
Informed consent is one of the cornerstones and requirements sine qua non of modern medical research and clinical practice. It developed relatively quickly to gain great importance, despite initial setbacks. The requirement of informed consent applies to all subjects of medical research and therapy, including persons with dementia (PwDs), whose impaired competence to provide valid informed consent poses particular challenges…
Differing Understandings of Informed Consent Held by Research Institutions, People with Intellectual Disability, and Guardians: Implications for Inclusive, Ethical Research [BOOK CHAPTER]
Differing Understandings of Informed Consent Held by Research Institutions, People with Intellectual Disability, and Guardians: Implications for Inclusive, Ethical Research [BOOK CHAPTER]
Britteny Howell, Karrie Shogren
Research Involving Participants with Cognitive Disability and Differences: Ethics, Autonomy, Inclusion, and Innovation, 5 September 2019; Chapter 3
Excerpt
Approximately 1–3% of the world’s population experiences an intellectual disability (ID)… Despite social and medical gains over the past several decades, people with ID are significantly more likely to experience poorer health and quality of life outcomes than people without… Research participation can play an important role in reducing such persistent disparities; however, people with ID remain under-represented in research for a variety of reasons, including the assumption that they are unable to provide informed consent for participation…
Using Ethnographic Methods to Determine Capacity to Consent amongst Individuals Diagnosed with Chronic Mental Illnesses [BOOK CHAPTER]
Using Ethnographic Methods to Determine Capacity to Consent amongst Individuals Diagnosed with Chronic Mental Illnesses [BOOK CHAPTER]
Saira A. Mehmood
Research Involving Participants with Cognitive Disability and Differences: Ethics, Autonomy, Inclusion, and Innovation, 5 September 2019; Chapter 14
Introduction
This chapter reports on an ethnographic research project conducted with people diagnosed with chronic mental illnesses and often economic and educational vulnerabilities as well. It focuses particularly on strategies for assessing capacity to consent…
Repurposing Ethnography to Assess Consent Capacity [BOOK CHAPTER]
Repurposing Ethnography to Assess Consent Capacity [BOOK CHAPTER]
Megan Wright
Research Involving Participants with Cognitive Disability and Differences: Ethics, Autonomy, Inclusion, and Innovation, 5 September 2019; Chapter 24
Introduction
Saira Mehmood illustrates how participant observation, an ethnographic method, can be applied to asses research consent capacity for persons with chronic mental illness who use mental health services at a non-profit organization. Through observation of and interaction with prospective participants and organization staff members, Mehmood was able to get a sense of a mental health service user’s decisional capacity and vulnerability. While this is a novel and beneficial approach to assessing consent capacity, questions remain about its application, appropriateness, and usefulness in other contexts.
Decisional capacity to consent to treatment and anaesthesia in patients over the age of 60 undergoing major orthopaedic surgery
Decisional capacity to consent to treatment and anaesthesia in patients over the age of 60 undergoing major orthopaedic surgery
Research Article
Gabriele Mandarelli, Giovanna Parmigiani, Felice Carabellese, Silvia Codella, Paolo Roma, Domitilla Brancadoro, Andrea Ferretti, Lucio Alessandro, Giovanni Pinto, Stefano Ferracuti
Medicine Science and the Law, 1 August 2019
Abstract
Despite growing attention to the ability of patients to provide informed consent to treatment in different medical settings, few studies have dealt with the issue of informed consent to major orthopaedic surgery in those over the age of 60. This population is at risk of impaired decision-making capacity (DMC) because older age is often associated with a decline in cognitive function, and they often present with anxiety and depressive symptoms, which could also affect their capacity to consent to treatment. Consent to major orthopaedic surgery requires the patient to understand, retain and reason about complex procedures. This study was undertaken to extend the literature on decisional capacity to consent to surgery and anaesthesia of patients over the age of 60 undergoing major orthopaedic surgery. Recruited patients (N=83) were evaluated using the Aid to Capacity Evaluation, the Beck Depression Inventory, the State–Trait Anxiety Inventory Y, the Mini-Mental State Examination and a visual analogue scale for measuring pain symptomatology. Impairment of medical DMC was common in the overall sample, with about 50% of the recruited patients showing a doubtful ability, or overt inability, to provide informed consent. Poor cognitive functioning was associated with reduced medical DMC, although no association was found between decisional capacity and depressive, anxiety and pain symptoms. These findings underline the need of an in-depth assessment of capacity in older patients undergoing major orthopaedic surgery.